Evidence map›Paper›PMID 28281186›Full record

ArticleMolecular and cellular biochemistry2017

Calcium-sensing receptor-mediated mitogen-activated protein kinase pathway improves the status of transplanted mouse embryonic stem cells in rats with acute myocardial infarction.

Jian Sun, Tao Wei, Shuzhi Bai, Hongtao Zhao, Xiaoqin Liu, Jinfeng Yu, Li Li, Gaochen Song, Hairong Luan, Changqing Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Cardioprotective Role of CalhexCell biochemistry and biophysics · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jian SunMudanjiang Medical University, Mudanjiang, China. mdjsunjian@126.com.
Tao WeiMudanjiang Medical University, Mudanjiang, China.
Shuzhi BaiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Hongtao ZhaoMudanjiang Medical University, Mudanjiang, China.
Xiaoqin LiuMudanjiang Medical University, Mudanjiang, China.
Jinfeng YuMudanjiang Medical University, Mudanjiang, China.
Li LiMudanjiang Medical University, Mudanjiang, China.
Gaochen SongMudanjiang Medical University, Mudanjiang, China.
Hairong LuanMudanjiang Medical University, Mudanjiang, China.
Changqing XuDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Mudanjiang Medical University · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have identified the critical role of calcium-sensing receptors (CaSRs) in cardiac ischaemia/reperfusion injury and cardiac hypertrophy and have demonstrated that CaSRs induce myocardial apoptosis by activating MAPKs. Using acute myocardial infarction rat models, we found that a combination therapy of CaSR inhibition and embryonic stem cell (ESC) transplantation after acute myocardial infarction (AMI) leads to a dramatic reduction in the infarct size; a significant increase in the maximum rising and falling rate (+dp/dtmax and -dp/dtmax, respectively) of left ventricular pressure; a significant decrease in left ventricular end-diastolic pressure; a significant decrease in the mRNA expression level of CaSR, Bax, Bcl-2, cleaved caspase-3, cleaved caspase-9, p-ERK, p-JNK and p-P38 protein together with apoptosis indexes in the C and E groups; and a significant decrease in cTnT levels as well as LDH and CK activity. These findings indicate that cardiac function could be enhanced significantly by combination therapy with CaSR inhibition and ESC transplantation; the effect was better than ESC transplantation alone, and the mechanism might be associated with a reduction in cell apoptosis via the inhibition of the MAPK pathway. Apoptosis could be reduced through CaSR, which regulates the MAPK pathway and apoptosis-related protein. Our study indicated that CaSR inhibitors have a pivotal role in the treatment of AMI.

Indexed as

MAP Kinase Signaling SystemMyocardial InfarctionStem Cell TransplantationAnimalsApoptosisApoptosis Regulatory ProteinsCell LineGene Expression RegulationHeterograftsMaleMiceMouse Embryonic Stem CellsRatsRats, WistarReceptors, Calcium-SensingReceptors, G-Protein-CoupledApoptosis Regulatory ProteinsCASR protein, mouseextracellular calcium cation-sensing receptor, ratReceptors, Calcium-SensingReceptors, G-Protein-CoupledAcute myocardial infarctionCalcium-sensing receptorCardiac functionCellular transplantEmbryonic stem cells

Identifiers

PMID28281186
OpenAlexW2594364140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.